An Efficacy and Safety Comparison Study of Two Marketed Drugs in Patients With Relapsing-remitting MS
Clinical trial NCT00206648 · COMPLETED
Trial details
- NCT number
- NCT00206648
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-03-01
- Enrollment
- 271
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.